Intrinsic Value

FEMY doesn't have a meaningful market cap.

The intrinsic value of Femasys Inc (FEMY) under the Base Case is 3.37 USD per share. Compared with the current market price of 1.56 USD, the stock appears Undervalued by 54% .

The intrinsic value is calculated using valuation multiples.

Do our valuations actually work? See backtest results .

FEMY Intrinsic Value
$3.37
Undervaluation 54%
Intrinsic Value
Price $1.56

FEMY is cheaper than usual. It was this cheap or cheaper on less than 1% of days in the past 5 years.

Monitor FEMY
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value $2.69
Get notified when the price drops into your buy zone
Intrinsic Value $3.37
Margin of Safety 20% $2.69
Current Price $1.56
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to FEMY

Fundamental Analysis

What Femasys Does

Health Care

Femasys is a women’s health medical device company that develops and sells products for fertility care, birth control, and gynecologic procedures. Its portfolio includes office-based tools doctors use to test and treat conditions involving the reproductive system, such as fallopian tube evaluation and other minimally invasive procedures.

Headquarters
United States of America US
Employees
51
IPO date
Jun 18, 2021
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Femasys Inc

Wall St Price Targets

Capital Returns

Competitive Landscape

Ownership

FEMY Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one FEMY stock?

The intrinsic value for Femasys Inc (FEMY) under the Base Case is 3.37 USD.

Is FEMY stock undervalued or overvalued?

Compared with the current market price of 1.56 USD, the stock appears Undervalued by 54% .

Back to Top